NetworkNewsBreaks

TuesdayOct 10, 2023 2:30 pm

NetworkNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Strategic Board Appointments of Two Finance Industry Experts

Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, today announced the appointment of Leni Boeren and Ruud Hendriks as independent directors. Both Boeren and Hendriks bring extensive, high-level experience in finance and business. Boeren has a 40-year career in the financial sector, commencing with banking roles at Paribas and Rabobank before holding several director-level positions at Amsterdam exchanges and then Euronext. Hendriks brings more than 35 years of experience in the asset management industry, having held senior roles at some of the most established financial institutions.…

Continue Reading

TuesdayOct 10, 2023 2:24 pm

NetworkNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) to Serve as Gold Sponsor of Synchrony Symposia 2023

PaxMedica (NASDAQ: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of autism spectrum disorder (“ASD”) and other serious conditions, today announced its Gold Sponsorship of The BRAIN Foundation's esteemed Synchrony Symposia 2023. The globally recognized event serves as a catalyst for translational research in autism and related neurodevelopmental disorders and brings together leading scientists, clinicians, biotech and pharmaceutical companies, venture partners, and community stakeholders to foster scientific advancements that can enhance the well-being and quality of life for individuals affected by ASD. “We are honored to support The BRAIN…

Continue Reading

TuesdayOct 10, 2023 2:13 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) CEO Featured in Latest Episode of The Bell2Bell Podcast

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, is featured in the latest Bell2Bell Podcast release. During the segment, podcast host Stuart Smith discusses the company with Clene president and CEO Rob Etherington, who explains Clene’s business model and provides an overview of recent developments, which provide hope to those affected by neurodegenerative conditions. The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries. “Clene spends every waking moment working on amyotrophic lateral sclerosis (‘ALS’), a devastating neurodegenerative condition,” said Clene president…

Continue Reading

TuesdayOct 10, 2023 1:56 pm

NetworkNewsBreaks – SOHM, Inc. (SHMN), UACI Collaborate to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology

SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, today announced its entry into development collaboration with the University of Arizona Center for Innovation (“UACI”) to propel ABBIE, a non-viral gene-editing kit technology. UACI is a leading science and tech startup incubator that is directly connected to the University of Arizona, which is renowned for its contributions to the scientific community, ranking among the nation’s top 50 public universities by U.S. News & World Report. “We are delighted to assist SOHM and the development of ABBIE technology,” said UACI Executive…

Continue Reading

TuesdayOct 10, 2023 12:59 pm

NetworkNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) Announces 30% Price Increase for Its SekurVPN

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a leading Swiss hosted secure and private communications platform, announced that, after discussions with its digital marketing team and careful consideration, it has decided to increase its prices for its Swiss hosted privacy VPN, SekurVPN. New signups for SekurVPN have increased recently and represent 60% of all new signups for the month of October. “We are very pleased with the progress we are making with SekurVPN signups in the last couple of months and we have decided to adjust our pricing upward after careful planning with our marketing team,” said Alain…

Continue Reading

TuesdayOct 10, 2023 11:02 am

NetworkNewsBreaks — SenesTech Inc. (NASDAQ: SNES) to Present at Upcoming Lytham Partners Investor Conference

SenesTech (NASDAQ: SNES), animal pest fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, will be participating in this month’s Lytham Partners Fall 2023 Investor Conference; the conference is slated for Oct. 17, 2023. According to the announcement, SenesTech CEO Joel Fruendt and CFO Tom Chesterman will present during the elite event. Their presentation is scheduled to begin at 7 a.m. ET. In addition, the two company officials will be available to host one-on-one meetings with investors. To view the presentation, visit https://nnw.fm/q5txo or https://nnw.fm/xWnTK To view the full press release, visit https://nnw.fm/RpskK About SenesTech…

Continue Reading

MondayOct 09, 2023 1:18 pm

NetworkNewsBreaks – IBN, BioMedWire to Provide Dedicated Media Coverage for Upcoming BioPharma Nexus Events

InvestorBrandNetwork (“IBN”), a dynamic communications organization, today announced its collaboration with BioPharma Nexus as an official media partner for its events this month. In addition, BioMedWire, a specialized communications platform dedicated to the life sciences sector and a key part of IBN’s Dynamic Brand Portfolio (“DBP”), will serve as an official media partner. For each of the events, IBN and BioMedWire will leverage advanced communications tools to provide dedicated coverage, including syndicated article dissemination throughout IBN’s extensive network of 5,000+ strategic partners, and offer updates on each event via IBN’s influential social media accounts. “It is a pleasure to work…

Continue Reading

MondayOct 09, 2023 1:08 pm

NetworkNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Emergency Communication Systems Deployed for Four Existing Customers

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, today announced new purchase orders. The orders are from four existing customers – two cities and two universities – seeking to grow and improve their emergency communications systems. The announcement reads, “Advocates, individuals and government officials at all levels must do everything they can to ensure that schools are safe places for students, teachers and other employees. A university in Delaware is expanding their 15-phone emergency communication system with 3 K1 Blue Light Emergency Phones. A Southern California university added Knightscope’s K1B Maintenance Plan…

Continue Reading

MondayOct 09, 2023 12:35 pm

NetworkNewsBreaks – ROTH MKM’s Upcoming Conference to Feature Public Healthcare Companies Across Multiple Sub-Sectors

ROTH MKM, a full-service investment bank focused on serving growth companies and their investors, today announced plans to host its 2023 Healthcare Opportunities Conference in New York City on Oct. 12, 2023. The event will provide pre-qualified institutional investors and healthcare industry professionals the opportunity to interact closely with C-level executives of approximately 25 public companies selected by ROTH’s research analysts. With a multiple sub-sector focus, the conference will feature participating companies operating in biotechnology, pharmaceuticals, medical technologies and oncology therapeutics. “Meaningful conversations between companies and a wide spectrum of investors will be the main focus of our Healthcare Opportunities…

Continue Reading

MondayOct 09, 2023 11:51 am

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Appoints Marianne McInerney as Chief Strategy Officer

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the appointment of Marianne McInerney as chief strategy officer. According to the announcement, McInerney will focus on growth opportunities and drive strategic initiatives for Mullen’s commercial, consumer vehicles and governmental affairs. McInerney has nearly two decades of experience in the automotive and transportation industry, during which she has advised multiple original equipment manufacturers, governmental entities and tier one suppliers and held vital positions at next-generation vehicle OEMs, the U.S. Department of Transportation, and the American International Automobile Dealers Association. “Marianne is a key addition to our team and…

Continue Reading